La Jolla Pharmaceutical Company - Product Pipeline Review - 2014
La Jolla Pharmaceutical Company - Product Pipeline Review...
partnered Products/combination Treatment Modalities 12
la Jolla Pharmaceutical Company - Pipeline Products Glance 13
la Jo...
list Of Tables
la Jolla Pharmaceutical Company, Key Information 5
la Jolla Pharmaceutical Company, Key Facts 5
la Jolla Ph...
Upcoming SlideShare
Loading in …5
×

La Jolla Pharmaceutical Company - Product Pipeline Review - 2014

337 views

Published on

This report provides comprehensive information on the current therapeutic developmental pipeline of La Jolla Pharmaceutical Companys, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Get Detail Report With TOC @ http://www.researchmoz.us/la-jolla-pharmaceutical-company-product-pipeline-review-2014-report.html

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Published in: Business
0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total views
337
On SlideShare
0
From Embeds
0
Number of Embeds
2
Actions
Shares
0
Downloads
2
Comments
0
Likes
0
Embeds 0
No embeds

No notes for slide

La Jolla Pharmaceutical Company - Product Pipeline Review - 2014

  1. 1. La Jolla Pharmaceutical Company - Product Pipeline Review - 2014 La Jolla Pharmaceutical Company - Product Pipeline Review - 2014 Summary Global Markets Directs, La Jolla Pharmaceutical Company - Product Pipeline Review - 2014, provides an overview of the La Jolla Pharmaceutical Companys pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of La Jolla Pharmaceutical Companys, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects. Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Directs proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Directs team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease. Scope - The report provides brief overview of La Jolla Pharmaceutical Company including business description, key information and facts, and its locations and subsidiaries - The report reviews current pipeline of La Jolla Pharmaceutical Companys human therapeutic division and enlists all their major and minor projects - The report features product description and descriptive mechanism of action for key pipeline products along with the products developmental history and major milestones - Special feature on out-licensed and partnered product portfolio - The report summarizes all the dormant and discontinued pipeline projects - Latest company statement - Latest news and deals relating to the La Jolla Pharmaceutical Companys pipeline products Reasons to buy - Evaluate La Jolla Pharmaceutical Companys strategic position with total access to detailed information on its product pipeline - Assess the growth potential of La Jolla Pharmaceutical Company in its therapy areas of focus - Identify new drug targets and therapeutic classes in the La Jolla Pharmaceutical Companys R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas - Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps - Develop strategic initiatives by understanding the focus areas of La Jolla Pharmaceutical Company and exploit collaboration and partnership opportunities - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Plan mergers and acquisitions effectively by identifying the most promising pipeline of La Jolla Pharmaceutical Company - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope - Explore the dormant and discontinued projects of La Jolla Pharmaceutical Company and identify potential opportunities in those areas - Avoid Intellectual Property Rights related issues Table Of Contents table Of Contents 2 list Of Tables 4 list Of Figures 4 la Jolla Pharmaceutical Company Snapshot 5 la Jolla Pharmaceutical Company Overview 5 key Information 5 key Facts 5 la Jolla Pharmaceutical Company - Research And Development Overview 6 key Therapeutic Areas 6 la Jolla Pharmaceutical Company - Pipeline Review 9 pipeline Products By Stage Of Development 9 pipeline Products - Monotherapy 10 pipeline Products - Partnered Products 11 La Jolla Pharmaceutical Company - Product Pipeline Review - 2014
  2. 2. partnered Products/combination Treatment Modalities 12 la Jolla Pharmaceutical Company - Pipeline Products Glance 13 la Jolla Pharmaceutical Company - Clinical Stage Pipeline Products 13 phase Ii Products/combination Treatment Modalities 13 phase I Products/combination Treatment Modalities 14 la Jolla Pharmaceutical Company - Early Stage Pipeline Products 15 preclinical Products/combination Treatment Modalities 15 discovery Products/combination Treatment Modalities 16 la Jolla Pharmaceutical Company - Drug Profiles 17 gcs-100 17 product Description 17 mechanism Of Action 17 r&d Progress 17 ljpc-501 19 product Description 19 mechanism Of Action 19 r&d Progress 19 ljpc-0712 20 product Description 20 mechanism Of Action 20 r&d Progress 20 ljpc-1010 21 product Description 21 mechanism Of Action 21 r&d Progress 21 ljpc-401 22 product Description 22 mechanism Of Action 22 r&d Progress 22 ljpc-6417 23 product Description 23 mechanism Of Action 23 r&d Progress 23 ljpc-101 24 product Description 24 mechanism Of Action 24 r&d Progress 24 ljpc-201 25 product Description 25 mechanism Of Action 25 r&d Progress 25 ljpc-301 26 product Description 26 mechanism Of Action 26 r&d Progress 26 la Jolla Pharmaceutical Company - Pipeline Analysis 27 la Jolla Pharmaceutical Company - Pipeline Products By Target 27 la Jolla Pharmaceutical Company - Pipeline Products By Route Of Administration 28 la Jolla Pharmaceutical Company - Pipeline Products By Molecule Type 29 la Jolla Pharmaceutical Company - Pipeline Products By Mechanism Of Action 30 la Jolla Pharmaceutical Company - Recent Pipeline Updates 31 la Jolla Pharmaceutical Company - Dormant Projects 36 la Jolla Pharmaceutical Company - Discontinued Pipeline Products 37 discontinued Pipeline Product Profiles 37 abetimus Sodium 37 gm-1485 37 la Jolla Pharmaceutical Company - Company Statement 38 la Jolla Pharmaceutical Company - Locations And Subsidiaries 41 head Office 41 other Locations & Subsidiaries 41 appendix 42 methodology 42 coverage 42 secondary Research 42 primary Research 42 expert Panel Validation 42 contact Us 43 disclaimer 4 La Jolla Pharmaceutical Company - Product Pipeline Review - 2014
  3. 3. list Of Tables la Jolla Pharmaceutical Company, Key Information 5 la Jolla Pharmaceutical Company, Key Facts 5 la Jolla Pharmaceutical Company - Pipeline By Indication, 2014 8 la Jolla Pharmaceutical Company - Pipeline By Stage Of Development, 2014 9 la Jolla Pharmaceutical Company - Monotherapy Products In Pipeline, 2014 10 la Jolla Pharmaceutical Company - Partnered Products In Pipeline, 2014 11 la Jolla Pharmaceutical Company - Partnered Products/ Combination Treatment Modalities, 2014 12 la Jolla Pharmaceutical Company - Phase Ii, 2014 13 la Jolla Pharmaceutical Company - Phase I, 2014 14 la Jolla Pharmaceutical Company - Preclinical, 2014 15 la Jolla Pharmaceutical Company - Discovery, 2014 16 la Jolla Pharmaceutical Company - Pipeline By Target, 2014 27 la Jolla Pharmaceutical Company - Pipeline By Route Of Administration, 2014 28 la Jolla Pharmaceutical Company - Pipeline By Molecule Type, 2014 29 la Jolla Pharmaceutical Company - Pipeline Products By Mechanism Of Action, 2014 30 la Jolla Pharmaceutical Company - Recent Pipeline Updates, 2014 31 la Jolla Pharmaceutical Company - Dormant Developmental Projects,2014 36 la Jolla Pharmaceutical Company - Discontinued Pipeline Products, 2014 37 la Jolla Pharmaceutical Company, Subsidiaries 41 list Of Figures la Jolla Pharmaceutical Company - Pipeline By Top 10 Indication, 2014 7 la Jolla Pharmaceutical Company - Pipeline By Stage Of Development, 2014 9 la Jolla Pharmaceutical Company - Monotherapy Products In Pipeline, 2014 10 la Jolla Pharmaceutical Company - Partnered Products In Pipeline, 2014 11 la Jolla Pharmaceutical Company - Pipeline By Top 10 Target, 2014 27 la Jolla Pharmaceutical Company - Pipeline By Top 10 Route Of Administration, 2014 28 la Jolla Pharmaceutical Company - Pipeline By Top 10 Molecule Type, 2014 29 la Jolla Pharmaceutical Company - Pipeline Products By Top 10 Mechanism Of Action, 2014 30 ResearchMoz(http://www.researchmoz.us/) is the one stop online destination to find and buy market research reports & Industry Analysis. We fulfill all your research needs spanning across industry verticals with our huge collection of market research reports. We provide our services to all sizes of organizations and across all industry verticals and markets. Our Research Coordinators have in-depth knowledge of reports as well as publishers and will assist you in making an informed decision by giving you unbiased and deep insights on which reports will satisfy your needs at the best price. Contact: M/s Sheela, 90 State Street, Suite 700, Albany NY - 12207 United States Tel: +1-518-618-1030 USA - Canada Toll Free 866-997-4948 Email: sales@researchmoz.us Website: http://www.researchmoz.us/ La Jolla Pharmaceutical Company - Product Pipeline Review - 2014

×